Legal Solutions to Support and Safeguard Global Product Launch

Get Help from Our Practice Groups Specialized in Pharma, Biotech, and Medical Devices

Learn More
Digital legal

TransPerfect Legal Solutions

Patent Translation & Foreign Filing

We simplify the patent translation and global filing process with our suite of comprehensive solutions for patent-related needs. TLS’s dedicated project managers, expert patent specialists, and highly qualified linguist pool help reduce translation costs, agency fees, administrative burdens, and turnaround times—without sacrificing quality or service.

Learn More

Litigation Support

When it comes to investigations and litigation support, TLS helps mitigate the challenges associated with e-discovery, privacy, and information security, and provides visibility into the discovery management process.

Learn More

Achieve Greatness in the Global Regulatory Landscape

Today, global sponsors are consistently challenged to bring products to market faster while facing evolving regulations with increased scrutiny. With the language barriers and collaboration logistics of global operations, clinical trials must be managed carefully to avoid unexpected increases in cost, time, and compliance risk. Having a global partner like TransPerfect by your side helps you focus on what matters most: saving lives.

Artificial Intelligence in Life Sciences

Latest Developments Presented by Industry Leaders

Improved Outcomes by the Numbers

Avoid challenges in bringing therapeutic products to market by protecting intellectual property and effectively navigating international legal matters.

  • Cut down high-volume data sets in multiple languages within stringent turnaround times
  • Rapidly collect, review, and produce discovery data from multiple custodians
  • Provide insights into potential threats and protect against data breaches
  • Translate and file a patent in 20 different countries

News and Press Releases

Our industry experts have in-depth understanding of the challenges, requirements, and goals for life sciences organizations involved in conducting clinical research.

XTalks | eCOA: Has It Lived Up to the Promise? A Realistic Assessment for Today's Trials

Despite two decades of technological advancement, the debate between paper and electronic clinical outcome assessments (eCOA) remains unresolved. This webinar revisits the assumptions that continue to shape data collection strategies and examines whether current practice reflects today’s eCOA capabilities or institutional habit. Paper is often framed as the “gold standard,” yet paper-based patient-reported outcome data can be incomplete, error-prone and difficult to ...

XTalks | eCOA: Has It Lived Up to the Promise? A Realistic Assessment for Today's Trials

Top 10 Pharma Company Overhauls Global COA Program,Cutting Costs by 33% and Errors to Near Zero

Inconsistent standards, stretched timelines, and limited visibility were straining a top 10 pharma company's COA program. Discover how TransPerfect Life Sciences' centralization strategy delivered 99.7% accuracy, 40% less PM oversight, and 33% cost savings across the ...

Four Years In: What the EU Clinical Trial Regulation Has (and Hasn't) Delivered

When the EU Clinical Trial Regulation (EU CTR No 536/2014) went live for new submissions on January 31, 2022, it promised to transform how clinical trials are authorized and conducted across Europe: a single submission, one decision, and harmonized oversight. Four years in,...

How to Make Your Academy Succeed at Global Scale—Lessons Learned on What Works and What Doesn’t

Most life sciences and MedTech companies launch a corporate academy with strong strategic intent, whether that’s executive sponsorship, a named platform, a dedicated budget, or a curriculum mapped to business goals. After launch, however, these same organizations all too often ...

IMP Labeling Workflows That Reduce Relabeling Risk and Start-Up Delays

Investigational medicinal product (IMP) labeling sits at the heart of clinical trial supply, impacting departments across pharmaceutical organizations, from clinical operations and regulatory affairs to quality assurance and beyond. When labeling activities are managed across ...

The Missing Link: Why Study Design Makes or Breaks a Clinical Trial

In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Farrell Healion, Founder and Principal Consultant at OptiTrial, to explore why study design is so often the overlooked "missing link" in clinical ...

C3 Summit 2026 - London

Conversations on Clinical Content, C3 Summit is part of a series of events hosted by TransPerfect Life Sciences featuring sessions with expert panels discussing present challenges, strategies, and innovations, as well as insights into future advancements, from R&D to ...

Get Global Legal Support.

How did you hear about us?
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.